Research Article
SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients via the Epigenetic Regulation of Cellular Quiescence
Table 2
Clinicopathological features of 42 NSCLC patients who received platinum-based combination chemotherapy.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NSCLC: nonsmall cell lung cancer. TAX: taxol. PEM: pemetrexed. GEM: gemcitabine. DTX: docetaxel. Platinum: cisplatin or carboplatin. |